Navigation Links
Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
Date:2/25/2011

f the currently available data and information, current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, our ability to commercialize KRYSTEXXA; our ability to retain the personnel whom we have hired and to hire the remaining personnel necessary to complete the build out of our commercial team; our reliance on third parties to manufacture, KRYSTEXXA; the risk that the market for KRYSTEXXA is smaller than we have anticipated; competition from existing therapies and therapies that are currently under development, including therapies that are significantly less expensive than KRYSTEXXA; our ability to gain market acceptance for KRYSTEXXA among physicians, patients, health care payors and others in the medical community; whether we are able to obtain financing, if needed; economic, political and other risks associated with foreign operations; risks of maintaining protection for our intellectual property; risks of an adverse determination in intellectual property litigation; and risks associated with stringent government regulation of the biopharmaceutical industry and other important factors set forth more fully in our reports filed with the Securities and Exchange Commission, to which investors are referred for further information. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements, which speak only as of the date of publication of this press release. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acqui
'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2010 Results Conference Call on Friday, February 25, 2011
2. Savient Closes Sale of $230 Million in Convertible Senior Notes
3. Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
4. Savient Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
5. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
6. Savient Pharmaceuticals Announces Search for CEO
7. Savient Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
8. Savient Pharmaceuticals Announces Expected Availability of KRYSTEXXA™ for Prescription and Reports Third Quarter 2010 Financial Results
9. Savient Pharmaceuticals to Hold Third Quarter 2010 Financial Results Conference Call on Friday, November 5, 2010
10. Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time
11. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire-iReach/ -- ChemImage announced ... discussing improvements in the development of imaging ... both normal and diseased tissue that minimizes ... surgical procedures, lowers surgical costs and potentially ... The clinical and scientific ...
(Date:9/17/2014)... Minn. , Sept. 17, 2014 ACIST ... global market leader of advanced imaging modalities for cardiology, ... System in two live cases at the Transcatheter Cardiovascular ... The cases were presented from Medstar Washington Hospital Center ... Hospital/Columbia University Medical Center ( New York, NY ...
(Date:9/17/2014)... 17, 2014  Millions of people suffer from neck and ... Recently the FDA approved the launch of a ... implant device developed by Spinal Kinetics, which may offer relief ... or arm pain. Hospital for Special Surgery (HSS), the number ... in New York City and in ...
Breaking Medicine Technology:Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2ACIST Launches HDi High-Definition IVUS 2ACIST Launches HDi High-Definition IVUS 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2
... Fenwal, Inc., a global medical technology company focused on ... names of 16 inspiring individuals inducted into the company,s 2010 ... than a decade, Fenwal has partnered with blood centers to ... in assuring medicine,s most vital natural resource -- blood -- ...
... Systems (NYSE: VAR ) today announced the execution ... to supply medical imaging subcomponents to Toshiba Medical Systems for ... will be booked over the period of the agreement. ... it marks the latest chapter in our 30+ year relationship ...
Cached Medicine Technology:2010 Inductees to the Fenwal Blood Donation Hall of Fame 22010 Inductees to the Fenwal Blood Donation Hall of Fame 3Varian Medical Systems Announces X-Ray Products Contract With Toshiba Medical Systems 2
(Date:9/17/2014)... New York, New York (PRWEB) September 17, 2014 ... ) filings involving the Conserve line of metal-on-metal ... litigation now underway in U.S. District Court, Northern ... to an updated Case List issued by the ... 15, 2014, at least 397 product liability claims ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 The Food ... today, September 17, 2014, to consider: , ... Therapy (TRT), and, 2. The potential ... , With the TRT litigation ongoing, an informally-organized litigation ... the dangers of testosterone replacement therapy. Among others, ZKB ...
(Date:9/17/2014)... StartX , a nonprofit technology accelerator ... of funding at its Summer Demo Day yesterday. The ... was the first such gathering held at StartX’s new, ... The presentations were delivered on an expansive stage built ... 2,000 square foot life science facility that opened last ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Cadiz ... treatments and cosmetic procedures to clients throughout Central ... of services is Collagen Induction Therapy. Using the ... are able to help clients correct a wide ... introduced this month, and Cadiz Laser Spa is ...
(Date:9/17/2014)... -- Present-day Europeans are the descendants of at ... a new study. Previous research suggested ... European farmers. But, a new genetic analysis involving ... descendants of Ancient North Eurasians. Nearly all present-day ... group, researchers from Harvard Medical School said. , ...
Breaking Medicine News(10 mins):Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 4Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 5Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 6Health News:Revolutionary Collagen Induction Therapy is Now Available at Cadiz Laser Spa 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3
... no health insurance don,t see a doctor all year ... children share at least one frightening fact: If they are ... health care... period. , New research from the University ... children in families earning between $38,000 and $77,000 annually who ...
... Universitys Slone Epidemiology Center have found that approximately one ... and cold medications during a given week. These ... Academic Societies & Asian Society for Pediatric Research Joint ... medications are widely marketed in the U.S. but surprisingly ...
... Two new studies conducted by researchers at Cincinnati Childrens ... parental job loss on childrens healthcare and the importance ... healthcare needs and reduce healthcare disparities. , The studies ... meeting of the Pediatric Academic Societies in Honolulu. , ...
... Calif., May 2 The following is,being issued ... protect,Kaiser facilities will launch an unfair labor practice ... Tuesday, May 6. This is the,first-ever group of ... and spied on workers who were trying to ...
... JUROR MISCONDUCT, LITTLE ROCK, Ark., May 2 ... suing Arkansas Children,s Hospital,over a wrong sided brain surgery ... "We have concerns about the accuracy of statements made ... has been a possibility of,juror misconduct," said attorney Phillip ...
... immunotherapy technique to help prevent the progression from ... simple, cost-effective technique are published May 2nd in ... an overwhelming need for effective immunotherapies for HIV, ... highly toxic. The authors, led by Professor ...
Cached Medicine News:Health News:Middle Class Uninsured Kids' Health Risk Almost as High as Poor Children's 2Health News:1 in 10 children using cough, cold medications 2Health News:US unemployment having impact on kids' health-care coverage -- and that puts their health at risk 2Health News:First-Ever Group of Hospital Security Officers to Strike over Unfair Labor Practices, Walk out of Facilities Across California on May 6 2Health News:Wrong-Sided Brain Surgery Trial Halted 2
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....
Inquire...
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Medicine Products: